Paper41997362
Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling.
Park K and 8 others. Cell Mol Gastroenterol Hepatol, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling. Papers, record 41997362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangitis, Sclerosing | Major topic |
| Transforming Growth Factor beta1 | Major topic |
| Smad Proteins | Major topic |
| Inflammation | Major topic |
| Animals | |
| Signal Transduction | |
| Mice | |
| Disease Models, Animal | |
| Humans | |
| Male | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Liver | |
| Liver Cirrhosis |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32243703 | Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. | Liver Int | 2020 | https://conductscience.org/library/papers/32243703 | PubMed |
| 2 | 12971963 | Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. | J Hepatol | 2003 | https://conductscience.org/library/papers/12971963 | PubMed |
| 3 | 12091489 | LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. | J Lipid Res | 2002 | https://conductscience.org/library/papers/12091489 | PubMed |
| 4 | 28030369 | Intestinal microbiota in primary sclerosing cholangitis. | Curr Opin Gastroenterol | 2017 | https://conductscience.org/library/papers/28030369 | PubMed |
| 5 | 30730351 | Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. | Am J Gastroenterol | 2019 | https://conductscience.org/library/papers/30730351 | PubMed |
| 6 | 28376583 | Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. | Gut Liver | 2018 | https://conductscience.org/library/papers/28376583 | PubMed |
| 7 | 31897266 | Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis. | J Anal Oncol | 2012 | https://conductscience.org/library/papers/31897266 | PubMed |
| 8 | 22993202 | Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. | Gut | 2013 | https://conductscience.org/library/papers/22993202 | PubMed |
| 9 | 19243003 | A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. | Liver Transpl | 2009 | https://conductscience.org/library/papers/19243003 | PubMed |
| 10 | 34247022 | Genomic analysis of Leuconostoc citreum TR116 with metabolic reconstruction and the effects of fructose on gene expression for mannitol production. | Int J Food Microbiol | 2021 | https://conductscience.org/library/papers/34247022 | PubMed |
| 11 | 37923895 | A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37923895 | PubMed |
| 12 | 35594710 | Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35594710 | PubMed |
| 13 | 24510619 | Dextran sulfate sodium (DSS)-induced colitis in mice. | Curr Protoc Immunol | 2014 | https://conductscience.org/library/papers/24510619 | PubMed |
| 14 | 36189347 | The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36189347 | PubMed |
| 15 | 21844910 | The intestinal microbiota and chronic disorders of the gut. | Nat Rev Gastroenterol Hepatol | 2011 | https://conductscience.org/library/papers/21844910 | PubMed |
| 16 | 34256014 | Gut-microbiota-targeted diets modulate human immune status. | Cell | 2021 | https://conductscience.org/library/papers/34256014 | PubMed |
| 17 | 33676893 | The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling. | J Biol Chem | 2021 | https://conductscience.org/library/papers/33676893 | PubMed |
| 18 | 26550019 | Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. | Evid Based Complement Alternat Med | 2015 | https://conductscience.org/library/papers/26550019 | PubMed |
| 19 | 30052539 | Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. | Eur J Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/30052539 | PubMed |
| 20 | 32633158 | Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis. | Scand J Gastroenterol | 2020 | https://conductscience.org/library/papers/32633158 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42097543 | From Kimchi to Primary Sclerosing Cholangitis: Leuconostoc citreum LB-P8 as a Microbiome-Based Therapeutic Approach. | Cell Mol Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42097543 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41997362
GET https://conductscience.org/api/papers/v1/41997362/references?page=2